Safflower injection
Function and Efficacy
Pharmacological experiments have shown that safflower injection can increase coronary blood flow and myocardial nutritional blood flow, directly or partially block alpha-adrenaline receptors to dilate blood vessels, and reduce total cholesterol, total esters, glyceryl trinitrate and esterified fatty acids in serum, as well as anti-thrombotic and platelet aggregation inhibitory effects; it can also protect brain tissue and have analgesic, sedative, anticonvulsant, anti-inflammatory, uterine and smooth muscle stimulating effects; it can also improve the cellular hypoxic state and the body's internal environment, increase the blood flow to organs such as the heart, brain, and liver, and improve microcirculation.
Ingredients
Safflower yellow, safflower glycoside, safflower pigment, and neosafflower glycoside.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| SAFFLOWER YELLOWIngredients |
It increases coronary blood flow and myocardial nutritional blood flow, has anti-thrombotic and platelet aggregation effects; improves cellular hypoxia and the body's internal environment, increases blood flow to organs such as the heart, brain, and liver, and improves microcirculation; it has protective, analgesic, sedative, anticonvulsant, anti-inflammatory, uterine excitatory, and smooth muscle excitatory effects on brain tissue. More |
36338-96-2 | 0 | |
| 4',5,7,8-TETRAHYDROXYFLAVANONEIngredients |
It increases coronary blood flow and myocardial nutritional blood flow, has anti-thrombotic and platelet aggregation effects; improves cellular hypoxia and the body's internal environment, increases blood flow to organs such as the heart, brain, and liver, and improves microcirculation; it has protective, analgesic, sedative, anticonvulsant, anti-inflammatory, uterine excitatory, and smooth muscle excitatory effects on brain tissue. More |
479-54-9 | 0 |
Appearance
The product is a yellow-red to brown-red clear liquid.
Usage and Dosage
Treatment of occlusive cerebrovascular disease: intravenous drip. 15 ml at a time, diluted with 250-500 ml of 10% glucose injection, once a day, 15-20 times as a course of treatment. Treatment of coronary heart disease: intravenous drip. 5-20 ml at a time, diluted with 250-500 ml of 5%-10% glucose injection, once a day, 10-14 times as a course of treatment, with an interval of seven to ten days. Treatment of vasculitis: intramuscular injection. 2.5-5 ml at a time, 1-2 times a day.
Adverse Reactions
1. Systemic damage: allergic reaction, anaphylactic shock, chills, fever, pale complexion, etc. 2. Respiratory damage: dyspnea, cough, wheezing, laryngeal edema, etc. 3. Cardiovascular damage: palpitations, arrhythmia, cyanosis, etc. 4. Central and peripheral nervous system damage: dizziness, headache, convulsions, etc. 5. Gastrointestinal damage: nausea, vomiting. 6. Skin and its appendages damage: rash, itching.
Precautions
1. Patients with a history of allergic or severe adverse reactions to this product or preparations containing safflower are prohibited from using this product. 2. Diabetic patients with abnormal coagulation function and fundus hemorrhage are prohibited from using this product. 3. Pregnant women, lactating women and children are prohibited from using this product.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed and protected from light.
Packaging Specification
5ml per bottle
Validity Period
24 months.
Manufacturer
Shanxi Huawei Pharmaceutical Co., Ltd.
-
Founded in:
1998-12-28 -
Address:
No. 8 Road, Huitong Industrial Park, Jinzhong Development Zone, Shanxi Demonstration Zone, Jinzhong City, Shanxi Province -
Tax NO.:
911407007136578385 -
Registered Funds:
58.83 million yuan -
Email: